The Asia Pacific Demineralized Bone Matrix Market would witness market growth of 6.5% CAGR during the forecast period (2023-2030).
The China market dominated the Asia Pacific Demineralized Bone Matrix Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $132.9 million by 2030. The Japan market is registering a CAGR of 5.8% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 7.2% during (2023 - 2030).
Surgeons employ DBM grafts to fill bone defects, support implant fixation, and facilitate the integration of orthopaedic implants. DBM’s osteoconductive properties promote implant osseointegration and enhance joint stability, improving patient mobility and quality of life. Additionally, DBM is commonly used in bone defect augmentation procedures to address bone loss resulting from trauma, tumor resection, or congenital abnormalities.
Surgeons utilize DBM grafts to reconstruct bone defects, restore bone volume, and provide structural support for surrounding tissues. DBM’s biocompatibility and osteogenic potential make it ideal for augmenting bone defects in various anatomical locations. Furthermore, DBM is a valuable adjunct in alveolar ridge preservation and sinus augmentation procedures in implant dentistry. Dentists utilize DBM grafts to augment bone volume, enhance implant stability, and promote osseointegration in edentulous areas.
The expansion of the medical equipment industry in India leads to the availability of advanced surgical technologies and equipment. This includes orthopaedic implants, instruments, and surgical tools in orthopaedic and dental surgeries. As per the data released by the India Brand Equity Foundation, the medical equipment industry in India is anticipated to reach a valuation of $50 billion by 2030. Therefore, the expansion of the medical device industry and the growing elderly population in the region is propelling the market’s growth.
Based on End-use, the market is segmented into Outpatient Facilities, and Hospitals. Based on Product Type, the market is segmented into Putty, Fiber, Sponge, Paste, Gel, and Others. Based on Application, the market is segmented into Spinal Fusion, Dental, Joint Reconstruction, Hand, Foot, & Ankle, Long Bone, and Craniomaxillofacial. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The China market dominated the Asia Pacific Demineralized Bone Matrix Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $132.9 million by 2030. The Japan market is registering a CAGR of 5.8% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 7.2% during (2023 - 2030).
Surgeons employ DBM grafts to fill bone defects, support implant fixation, and facilitate the integration of orthopaedic implants. DBM’s osteoconductive properties promote implant osseointegration and enhance joint stability, improving patient mobility and quality of life. Additionally, DBM is commonly used in bone defect augmentation procedures to address bone loss resulting from trauma, tumor resection, or congenital abnormalities.
Surgeons utilize DBM grafts to reconstruct bone defects, restore bone volume, and provide structural support for surrounding tissues. DBM’s biocompatibility and osteogenic potential make it ideal for augmenting bone defects in various anatomical locations. Furthermore, DBM is a valuable adjunct in alveolar ridge preservation and sinus augmentation procedures in implant dentistry. Dentists utilize DBM grafts to augment bone volume, enhance implant stability, and promote osseointegration in edentulous areas.
The expansion of the medical equipment industry in India leads to the availability of advanced surgical technologies and equipment. This includes orthopaedic implants, instruments, and surgical tools in orthopaedic and dental surgeries. As per the data released by the India Brand Equity Foundation, the medical equipment industry in India is anticipated to reach a valuation of $50 billion by 2030. Therefore, the expansion of the medical device industry and the growing elderly population in the region is propelling the market’s growth.
Based on End-use, the market is segmented into Outpatient Facilities, and Hospitals. Based on Product Type, the market is segmented into Putty, Fiber, Sponge, Paste, Gel, and Others. Based on Application, the market is segmented into Spinal Fusion, Dental, Joint Reconstruction, Hand, Foot, & Ankle, Long Bone, and Craniomaxillofacial. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
List of Key Companies Profiled
- Zimmer Biomet Holdings, Inc.
- Medtronic PLC
- Johnson & Johnson
- Stryker Corporation
- Arthrex, Inc.
- Globus Medical, Inc.
- Berkeley Advanced Biomaterials
- Xtant Medical Holdings, Inc.
- Orthofix Medical Inc.
- Institut Straumann AG
Market Report Segmentation
By End-use- Outpatient Facilities
- Hospitals
- Putty
- Fiber
- Sponge
- Paste
- Gel
- Others
- Government
- Energy
- Defense
- Agriculture & Forestry
- Media & Entertainment
- Civil Engineering & Archaeology
- Others
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Asia Pacific Demineralized Bone Matrix Market by End-use
Chapter 5. Asia Pacific Demineralized Bone Matrix Market by Product Type
Chapter 6. Asia Pacific Demineralized Bone Matrix Market by Application
Chapter 7. Asia Pacific Demineralized Bone Matrix Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Zimmer Biomet Holdings, Inc.
- Medtronic PLC
- Johnson & Johnson
- Stryker Corporation
- Arthrex, Inc.
- Globus Medical, Inc.
- Berkeley Advanced Biomaterials
- Xtant Medical Holdings, Inc.
- Orthofix Medical Inc.
- Institut Straumann AG
Methodology
LOADING...
